Solid Biosciences Inc (NAS:SLDB)
$ 8.51 -0.61 (-6.69%) Market Cap: 326.61 Mil Enterprise Value: 169.77 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 40/100

Solid Biosciences Inc. - Special Call Transcript

Mar 15, 2021 / 08:30PM GMT
Release Date Price: $142.65 (-0.11%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Solid Biosciences IGNITE DMD data review call. (Operator Instructions) Now it is my pleasure to introduce to you our speaker today, Mr. Tim Palmer, Corporate Communications Manager. Sir, the floor is yours.

Tim Palmer
Solid Biosciences Inc. - Corporate Communications Manager

Good afternoon. Thank you, operator. Before we get started, I would like to remind everyone that during today's conference call, we may make forward-looking statements, including statements about the company's financial results, financial guidance, future business strategies and operations, and product development and regulatory progress, including statements about the ongoing IGNITE DMD clinical trial. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact of the COVID-19 pandemic, and other risks described in the Risk Factors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot